Glioma
Conditions
Keywords
glioma
Brief summary
Participation in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This trial will admit a wide range of data on the clinical trial experience of glioma patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future glioma patients.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Confirmed diagnosis of glioma * Participant must be 18 years of age or older * Participant must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, and other requirements of the study.
Exclusion criteria
* Pregnant or lactating woman * Participant is actively receiving study therapy in another * Inability to provide written informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of patients who decide to enroll in a glioma clinical research. | 3 months |
| Number of glioma study participants who remain in clinical study until completion. | 12 months |
Countries
United States
Contacts
Primary ContactMichael B Gill
Outcome results
None listed